Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis

Experimental Parasitology

Volumn 123, Issue 2, 2009, Pages 199-202

  Cardona, Nestor ^a   de la Torre, Alejandra ^a   Siachoque, Heber ^b   Patarroyo, Manuel A ^b,c   Gomez Marin, Jorge E ^a  

^a Facultad de Ciencias de la Salud   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

^c FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

Author keywords

Human antibodies; Peptides; SAG1; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PROTEIN P30;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHORIORETINOPATHY; CLINICAL ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; EYE INFECTION; HUMAN; HUMORAL IMMUNITY; INFANT; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE IMMUNITY; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

AMINO ACID SEQUENCE; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, PROTOZOAN; ANTIGENS, SURFACE; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; INFANT; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTOZOAN PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL; TOXOPLASMOSIS, OCULAR;

MUS; TOXOPLASMA GONDII;

EID: 68949194535     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.06.017     Document Type: Article

References (12)

1. Beghetto E., Spadoni A., Buffolano W., Del Pezzo M., Minenkova O., Pavoni E., Pucci A., Cortese R., Felici F., and Gargano N. Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. International Journal of Parasitology 33 (2003) 163-173
2. de-la-Torre A., Gonzalez G., Diaz-Ramirez J., and Gomez-Marin J.E. Screening by ophthalmoscopy for toxoplasma retinochoroiditis in Colombia. American Journal of Ophthalmology 143 (2007) 354-356
3. Gallego-Marín C., Henao A.C., and Gómez-Marín J.E. Clinical validation of a Western blot assay for congenital toxoplasmosis and newborn screening in a hospital in armenia (Quindio) Colombia. Journal of Tropical Pediatrics 52 (2006) 107-112
4. Godard I., Estaquier J., Zenner L., Bossus M., Auriault C., Darcy F., Gras-Masse H., and Capron A. Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Molecular Immunology 31 (1994) 1353-1363
5. Gómez Marín J.E., Castaño J.C., and Montoya M.T. A maternal screening program for congenital toxoplasmosis in Quindio (Colombia) and application of mathematical models to estimate incidence using age-stratified data. American Journal of Tropical Medicine and Hygiene 57 (1997) 180-186
6. Graille M., Stura E.A., Bossus M., Muller B.H., Letourneur O., Battail-Poirot N., Sibaï G., Gauthier M., Rolland D., Le Du M.H., and Ducancel F. Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune response. Journal of Molecular Biology 354 (2005) 447-458
7. Kato M., Claveria F.G., Maki Y., Sanda K., Tanaka T., Omata Y., Nagasawa H., and Suzuki N. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and beverley strain-induced anti-Toxoplasma gondii antibodies. Pathobiology 74 (2007) 50-56
8. Merrifield R. Solid phase synthesis I. Synthesis of a tetrapeptides. Journal of American Chemical Synthesis 85 (1963) 2149-2154
9. Patarroyo M.E., and Patarroyo M.A. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines. Accounts of Chemical Research 41 (2008) 377-386
10. Siachoque H., Guzman F., Burgos J., Patarroyo M.E., and Gomez-Marin J.E. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Experimental Parasitology 114 (2006) 62-65
11. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Procedures of the National Academy Sciences of the United States of America 85 (1988) 5409-5413
12. Velge-Roussel F., Chardès T., Mévélec P., Brillard M., Hoebeke J., and Bout D. Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Molecular and Biochemical Parasitology 66 (1994) 31-38